Accession Number: | 0001209191-23-025386 |
Date: | 2023-04-20 |
Issuer: | KRONOS BIO, INC. (KRON) |
Original Submission Date: |
DANSEY ROGER D
C/O KRONOS BIO, INC.
1300 SO. EL CAMINO REAL, SUITE 400
SAN MATEO, CA 94402
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
DIRECTOR STOCK OPTION (RIGHT TO BUY) | 1.28 | 2023-04-20 | deemed execution date | A | 68,000 (a) | 2033-04-19 | common stock 68,000 | $1.28 | 68,000 | direct |
ID | footnote |
---|---|
f1 | the shares subject to the option shall vest in three equal annual installments following the date of grant. |